Finch Therapeutics Group
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Finch Therapeutics Group's balance sheet done over the years? Its assets were worth $55,373,000 last year, which is less than in the previous period. 59% of Finch Therapeutics Groupโ€™s total assets is currently financed by debt. Its liabilities reached the amount of $32,487,000, which means an decrease by -52% compared compared to last year.

Debt to Assets

Finch Therapeutics Group, Inc. (NASDAQ:FNCH): Debt to assets
2019 103569000 163.10M 157.48%
2020 165338000 261.05M 157.89%
2021 225369000 23.14M 10.27%
2022 162939000 67.22M 41.26%
2023 55373000 32.48M 58.67%

FNCH Balance Sheet (2019 โ€“ 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
25.12M71.03M133.48M99.71M42.18M
Short term investments
00000
Net receivables
0144K494K1.09M4.74M
Inventory
0-3.51M-9.07M01
Other current assets
723K3.36M8.57M5.35M1.69M
Total current assets
25.84M71.03M133.48M106.16M48.62M
Non-current assets:
Property, Plant and Equipment
27.17M48.68M24.68M7.00M3.77M
Goodwill
0018.05M18.05M18.05M
Intangible assets
032.9M32.9M32.9M32.9M
Long term investments
02.56M2.26M200K210K
Other non-current assets
2.34M-5.89M7.21M-3.70M-4.69M
Total non-current assets
29.52M91.90M91.88M59.17M54.94M
Total assets
55.37M162.93M225.36M165.33M103.56M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
-1.72M003.37M2.37M
Short term debt
3.44M3.43M1.12M00
Total current liabilities
4.08M14.68M14.79M11.48M7.32M
Non-current liabilities:
Long term debt
56.80M48.90M4.88M1.80M143.66M
Deferred tax
00000
Other non-current liabilities
-28.40M14.85M23.14M234.04M364K
Total non-current liabilities
28.40M67.22M23.14M249.57M155.77M
Total liabilities
32.48M67.22M23.14M261.05M163.10M
Data sourceData sourceData source